Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

132
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
132
Factors Influencing Drug Absorption: Presystemic Elimination01:24

Factors Influencing Drug Absorption: Presystemic Elimination

420
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
420
Drug Distribution: Overview01:11

Drug Distribution: Overview

388
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
388
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

585
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
585
Volume of Distribution01:20

Volume of Distribution

566
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
566
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.9K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV seroprevalence, incidence, and viral suppression among Ugandan female bar workers: a population-based study.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Associations between Local and State Structural Stigma, Minority stress, and Mental Health in a Nationwide Sample of Sexual Minority Adolescents.

Child & adolescent social work journal : C & A·2026
Same author

Psychosocial stressors related to extreme weather events and multiple resource insecurities: qualitative insights from refugee youth in an Ugandan humanitarian setting.

SSM. Mental health·2026
Same author

Factors shaping understanding and interpretation of sexual practice survey questions in south-central Uganda: A qualitative analysis of cognitive interviews.

African journal of AIDS research : AJAR·2026
Same author

Health factors, stigma, and psychosocial resources associated with self-rated health: a cross-sectional analysis of the People Living with HIV Stigma Index 2.0 in Bolivia.

Lancet regional health. Americas·2026
Same author

Experiences of drought and flooding, resource insecurity, and sexual health among youth in Nairobi and Kisumu, Kenya: qualitative multi-method findings.

Sexual health·2026
Same journal

VIR-SAAF: a study protocol for a national decentralised randomised controlled trial of home-based sleep apnoea screening in patients with atrial fibrillation in Denmark.

BMJ open·2026
Same journal

Korean translation, cultural adaptation and psychometric validation of the revised patients' attitudes towards deprescribing questionnaire for caregivers.

BMJ open·2026
Same journal

MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.

BMJ open·2026
Same journal

Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada.

BMJ open·2026
Same journal

Investigation of barriers and facilitators to implementing a randomised controlled trial during health emergency using the PEARLES framework: insights from the coverage Africa trial on COVID-19 treatments in Burkina Faso.

BMJ open·2026
Same journal

Cost-effectiveness of immediate septoplasty versus medical management with the option for delayed septoplasty for nasal airways obstruction: a multicentre, open-label, randomised controlled trial.

BMJ open·2026
See all related articles

Related Experiment Video

Updated: Oct 3, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.4K

PrEP distribution in pharmacies: a systematic review.

Caitlin E Kennedy1, Ping Teresa Yeh1, Kaitlyn Atkins1

  • 1Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

BMJ Open
|February 22, 2022
PubMed
Summary
This summary is machine-generated.

Providing pre-exposure prophylaxis (PrEP) through pharmacies is feasible and acceptable to users and stakeholders. However, limited effectiveness data and service requirements necessitate further research for global HIV prevention goals.

Keywords:
HIV & AIDSorganisation of health servicespreventive medicinepublic health

More Related Videos

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

10.8K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Related Experiment Videos

Last Updated: Oct 3, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.4K
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

10.8K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Area of Science:

  • Public Health
  • HIV Prevention
  • Pharmaceutical Services

Background:

  • Novel service delivery models are needed to increase access to pre-exposure prophylaxis (PrEP) for HIV prevention.
  • Pharmacy-based PrEP provision offers a potential avenue to reach more individuals.

Purpose of the Study:

  • To systematically review the effectiveness, user and health worker values and preferences, and cost of initiating and continuing PrEP through pharmacies.
  • To assess the feasibility and acceptability of pharmacy-based PrEP access.

Main Methods:

  • Systematic review of studies on pharmacy-based PrEP access.
  • Searches conducted in PubMed, CINAHL, LILACS, and EMBASE up to December 2, 2020.
  • Inclusion of data from case studies, user/provider preferences, and cost analyses.

Main Results:

  • No studies met inclusion criteria for PrEP initiation or continuation effectiveness.
  • Six case studies demonstrated the feasibility of pharmacy-based PrEP programs in the USA.
  • Eleven studies indicated user and health worker acceptability across the USA, Kenya, and South Africa, with varying preferences for pharmacy versus clinic settings.

Conclusions:

  • Pharmacy-based PrEP provision is feasible and acceptable in multiple settings.
  • Limited evidence on effectiveness and service requirements may hinder widespread adoption.
  • Further research is essential to confirm the safety and efficacy of pharmacy access for achieving global HIV prevention targets.